Skip to main content
. 2017 May 16;7:1986. doi: 10.1038/s41598-017-02140-1

Table 3.

Determinants of coexisting BK virus nephropathy and acute rejection.

Factor Crude OR 95% CI p Value Adjusted OR# 95% CI p Value
Lower Upper Lower Upper
Tacrolimus use (reference: no) 0.400 0.022 7.201 0.534 0.365 0.017 8.021 0.522
Tacrolimus serum trough level within 3 months prior to renal biopsy
 Mean (ng/mL) 0.770 0.499 1.188 0.237 0.839 0.544 1.294 0.428
 Standard deviation (ng/mL) 1.521 0.663 3.489 0.322 1.825 0.711 4.680 0.211
 Coefficient of variance (%) 1.079 1.007 1.156 0.031* 1.068 1.003 1.137 0.039*
 Sirolimus use (reference: no) 14.875 2.198 100.656 0.006* 10.490 1.429 76.975 0.021*
Sirolimus serum trough level within 3 months prior to renal biopsy
 Mean (ng/mL) 1.239 0.631 2.429 0.534 1.377 0.637 2.979 0.416
 Standard deviation (ng/mL) 1.741 0.691 4.387 0.239 1.706 0.568 5.120 0.341
 Coefficient of variance (%) 1.065 0.949 1.194 0.283 1.067 0.929 1.226 0.356

#Adjusted models were adjusted for a propensity score consisting of recipient age, gender, deceased donor, transplantation vintage, diabetes mellitus, hypertension, congestive heart failure, albumin, estimated glomerular filtration rate according to the CKD-EPI formula, and absolute lymphocyte count. Abbreviations: OR, odds ratio; CI, confidence interval. *p < 0.05.